Insurer and out‐of‐pocket costs of osteoarthritis in the US: Evidence from national survey data

Abstract

The health care cost burden associated with OA is quite large for all groups examined and is disproportionately higher for women. Although insurers bear the brunt of treatment costs for OA, the OOP costs are also substantial.